Stanley S. Biological nanoparticles and their influence on organisms[J]. Curr Opin Biotechnol, 2014, 28C：69-74.
[2]
Laufberger V. Sur la cristallisation de la ferritine[J]. Bull Soc Chim Biol, 1937, 19：1575-1582.
[3]
Gerrity RG, Thomas K, Rosenthal J, et al. Accumulation of ferritin in the aortic intima of hyperlipemic swine[C]. New York：Journal of Cell Biology, 1981：A417.
[4]
Hampton JC. An electron microscope study of the source and distribution of ferritin in hepatic parenchymal cells of the newborn rabbit[J]. Blood, 1960, 15：480-490.
[5]
David CN, Easterbrook K. Ferritin in the fungus Phycomyces[J]. J Cell Biol, 1971, 48（1）：15-28.
[6]
Towe KM. Structural distinction between ferritin and iron-dextran（imferon）. An electron diffraction comparison[J]. J Biol Chem, 1981, 256（18）：9377-9378.
[7]
Barnés CM, Theil EC, Raymond KN. Iron uptake in ferritin is blocked by binding of[Cr（TREN）（H2O）（OH）]2+, a slow dissociating model for[Fe（H2O）6]2+[J]. Proceedings of the National Academy of Sciences, 2002, 99（8）：5195-5200.
[8]
Harrison PM, Arosio P. The ferritins：molecular properties, iron storage function and cellular regulation[J]. Biochim Biophys Acta, 1996, 1275（3）：161-203.
[9]
Cozzi A, Corsi B, Levi S, et al. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells：in vivo role of ferritin ferroxidase activity[J]. J Biol Chem, 2000, 275（33）：25122-25129.
[10]
Levi S, Yewdall SJ, Harrison PM, et al. Evidence that H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin[J]. Biochemistry J, 1992（288）：591-596.
[11]
Arosio P, Ingrassia R, Cavadini P. Ferritins：a family of molecules for iron storage, antioxidation and more[J]. Biochim Biophys Acta, 2009, 1790（7）：589-599.
[12]
Blake DR, Bacon PA, Eastham EJ, et al. Synovial fluid ferritin in rheumatoid arthritis[J]. Br Med J, 1980, 281（6242）：715-716.
[13]
Santambrogio P, Pinto P, Levi S, et al. Effects of modifications near the 2-, 3- and 4-fold symmetry axes on human ferritin renaturation[J]. Biochem J, 1997, 322（Pt 2）：461-468.
[14]
Kang S, Oltrogge LM, Broomell CC, et al. Controlled assembly of bifunctional chimeric protein cages and composition analysis using noncovalent mass spectrometry[J]. J Am Chem Soc, 2008, 130（49）：16527-16529.
[15]
Uchida M, Kang S, Reichhardt C, et al. The ferritin superfamily：Supramolecular templates for materials synthesis[J]. Biochim Biophys Acta, 2010, 1800（8）：834-845.
[16]
Lin X, Xie J, Niu G, et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging[J]. Nano Lett, 2011, 11（2）：814-819.
[17]
Mann S, Archibald DD, Didymus JM, et al. Crystallization at inorganic-organic interfaces：biominerals and biomimetic synthesis[J]. Science, 1993, 261（5126）：1286-1292.
[18]
Andrews NC. Forging a field：the golden age of iron biology[J]. Blood, 2008, 112（2）：219-230.
[19]
Alkhateeb AA, Connor JR. Nuclear ferritin：A new role for ferritin in cell biology[J]. Biochim Biophys Acta, 2010, 1800（8）：793-797.
[20]
Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician[J]. Blood Rev, 2009, 23（3）：95-104.
[21]
Volpino P, Cangemi V, Caputo V, et al. Clinical usefulness of serum ferritin measurements in lung cancer patients[J]. J Nucl Med Allied Sci, 1984, 28（1）：27-30.
[22]
Almeida SM, Cunha S, Yamada E, et al. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration[J]. Arq Neuropsiquiatr, 2008, 66（3B）：720-724.
[23]
Zhang XZ, Su AL, Hu MQ, et al. Elevated serum ferritin levels in patients with hematologic malignancies[J]. Asian Pac J Cancer Prev, 2014, 15（15）：6099-6101.
[24]
Wang W, Knovich MA, Coffman LG, et al. Serum ferritin：Past, present and future[J]. Biochim Biophys Acta, 2010, 1800（8）：760-769.
[25]
Reissmann KR, Dietrich MR. On the presence of ferritin in the peripheral blood of patients with hepatocellular disease[J]. J Clin Invest, 1956, 35（6）：588-595.
[26]
Chen H, Yeh J, Wang L, et al. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling peo-b-p gamma amps copolymer coating[J]. Biomaterials, 2010, 20（31）：5397-5407.
[27]
Fan K, Cao C, Pan Y, et al. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues[J]. Nat Nanotechnol, 2012, 7（7）：459-464.
[28]
Fan K, Cao C, Pan Y, et al. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues[J]. Nat Nanotechnol, 2012, 7（7）：459-464.
[29]
Dreher MR, Liu W, Michelich CR, et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers[J]. J Natl Cancer Inst, 2006, 98（5）：335-344.
[30]
Gilad AA, Winnard PJ, van Zijl PC, et al. Developing MR reporter genes：promises and pitfalls[J]. NMR Biomed, 2007, 20（3）：275-290.
[31]
Cohen B, Ziv K, Plaks V, et al. Ferritin nanoparticles as magnetic resonance reporter gene[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2009, 1（2）：181-188.
[32]
Li X, Qiu L, Zhu P, et al. Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting[J]. Small, 2012, 8（16）：2505-2514.
[33]
Kang HJ, Kang YJ, Lee YM, et al. Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform[J]. Biomaterials, 2012, 33（21）：5423-5430.
[34]
Aime S, Frullano L, Geninatti CS. Compartmentalization of a gadolinium complex in the apoferritin cavity：a route to obtain high relaxivity contrast agents for magnetic resonance imaging[J]. Angew Chem Int Ed Engl, 2002, 41（6）：1017-1019.
[35]
Terashima M, Uchida M, Kosuge H, et al. Human ferritin cages for imaging vascular macrophages[J]. Biomaterials, 2011, 32（5）：1430-1437.
[36]
Naumova AV, Reinecke H, Yarnykh V, et al. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart[J]. Mol Imaging, 2010, 9（4）：201-210.
[37]
Sun C, Yang H, Yuan Y, et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging[J]. J Am Chem Soc, 2011, 133（22）：8617-8624.
[38]
Liu G, Wu H, Wang J, et al. Apoferritin-templated synthesis of metal phosphate nanoparticle labels for electrochemical immunoassay[J]. Small, 2006, 2（10）：1139-1143.
[39]
Lee EJ, Ahn KY, Lee JH, et al. A novel bioassay platform using ferritin-based nanoprobe hydrogel[J]. Adv Mater, 2012, 24（35）：4739-4744, 4730.
[40]
Li CQ, Soistman E, Carter DC. Ferritin nanoparticle technology. A new platform for antigen presentation and vaccine development[J]. Industrial Biotechnology, 2006, 2（2）：143-147.
[41]
Han J, Kang YJ, Shin C, et al. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell（DC）-based vaccine development[J]. Nanomedicine：Nanotechnology, Biology and Medicine, 2014, 10（3）：561-569.
[42]
Gao L, Zhuang J, Nie L, et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles[J]. Nat Nanotechnol, 2007, 2（9）：577-583.
[43]
O''Leary TJ. Standardization in immunohistochemistry[J]. Appl Immunohistochem Mol Morphol, 2001, 9（1）：3-8.
[44]
Uchida M, Terashima M, Cunningham CH, et al. A human ferritin iron oxide nano-composite magnetic resonance contrast agent[J]. Magn Reson Med, 2008, 60（5）：1073-1081.
[45]
Lee LA, Wang Q. Adaptations of nanoscale viruses and other protein cages for medical applications[J]. Nanomedicine, 2006, 2（3）：137-149.
[46]
Lin X, Xie J, Zhu L, et al. Hybrid ferritin nanoparticles as activatable probes for tumor imaging[J]. Angew Chem Int Ed Engl, 2011, 50（7）：1569-1572.
[47]
Ji T, Zhao Y, Wang J, et al. Tumor fibroblast specific activation of a hybrid ferritin nanocage-based optical probe for tumor microenvironment imaging[J]. Small, 2013, 9（14）：2427-2431.
[48]
Li K, Zhang ZP, Luo M, et al. Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells[J]. Nanoscale, 2012, 4（1）：188-193.
[49]
Geninatti CS, Bussolati B, Tei L, et al. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe[J]. Cancer Res, 2006, 66（18）：9196-9201.
[50]
Huang P, Rong P, Jin A, et al. Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy[J]. Adv Mater, 2014, 26（37）：6401-6408.
[51]
Kitagawa T, Kosuge H, Uchida M, et al. RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease[J]. Mol Imaging Biol, 2012, 14（3）：315-324.
[52]
Li M, Mann S. DNA-directed assembly of multifunctional nanoparticle networks using metallic and bioinorganic building blocks[J]. J Mater Chem, 2004, 14（14）：2260-2263.
[53]
Zhao J, Liu M, Zhang Y, et al. Apoferritin protein nanoparticles dually labeled with aptamer and horseradish peroxidase as a sensing probe for thrombin detection[J]. Anal Chim Acta, 2013, 759：53-60.
[54]
Lee SH, Lee H, Park JS, et al. A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles[J]. FASEB J, 2007, 21（7）：1324-1334.
[55]
Liang M, Fan K, Zhou M, et al. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection[J]. Proc Natl Acad Sci USA, 2014, 111（41）：14900-14905.
[56]
Kanekiyo M, Wei CJ, Yassine H M, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies[J]. Nature, 2013, 499（7456）：102-106.
[57]
Lippert PC, Zachos JC. A biogenic origin for anomalous fine-grained magnetic material at the Paleocene-Eocene boundary at Wilson Lake, New Jersey[J]. Paleoceanography, 2007, 22（4）. DOI：10.1029/2007PA001471.
[58]
Theil EC, Behera RK, Tosha T. Ferritins for Chemistry and for Life[J]. Coord Chem Rev, 2013, 257（2）：579-586.
[59]
Theil EC. Ferritin protein nanocages-the story[J]. Nanotechnol Percept, 2012, 8（1）：7-16.
[60]
Worwood M, Aherne W, Dawkins S, et al. The characteristics of ferritin from human tissues, serum and blood cells[J]. Clin Sci Mol Med, 1975, 48：441-451.
[61]
Proudhon D, Briat JF, Lescure AM. Iron induction of ferritin synthesis in soybean cell suspensions[J]. Plant Physiol, 1989, 90（2）：586-590.
[62]
Andrews SC, Harrison PM, Guest JR. Cloning, sequencing, and mapping of the bacterioferritin gene（bfr）of Escherichia coli K-12[J]. J Bacteriol, 1989, 171（7）：3940-3947.
[63]
Harrison PM, Fischbach FA, Hoy TG, et al. Ferric oxyhydroxide core of ferritin[J]. Nature, 1967, 216（5121）：1188-1190.
[64]
Theil EC. Ferritin protein nanocages use ion channels, catalytic sites, and nucleation channels to manage iron/oxygen chemistry[J]. Curr Opin Chem Biol, 2011, 15（2）：304-311.
[65]
Schwartz JK, Liu XS, Tosha T, et al. Spectroscopic definition of the ferroxidase site in M ferritin：comparison of binuclear substrate vs cofactor active sites[J]. J Am Chem Soc, 2008, 130（29）：9441-9450.
[66]
Torti FM, Torti SV. Regulation of ferritin genes and protein[J]. Blood, 2002, 99（10）：3505-3516.
[67]
Lawson DM, Artymiuk PJ, Yewdall SJ, et al. Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts[J]. Nature, 1991, 349（6309）：541-544.
[68]
Meyron-Holtz EG, Moshe-Belizowski S, Cohen LA. A possible role for secreted ferritin in tissue iron distribution[J]. J Neural Transm, 2011, 118（3）：337-347.
[69]
Beck JR, Meier FA, French EE, et al. Serum-ferritin[J]. Lancet, 1979, 1（8125）：1080.
[70]
Sindic CJ, Collet-Cassart D, Cambiaso CL, et al. The clinical relevance of ferritin concentration in the cerebrospinal fluid[J]. J Neurol Neurosurg Psychiatry, 1981, 44（4）：329-333.
[71]
Stefanini S, Cavallo S, Wang CQ, et al. Thermal stability of horse spleen apoferritin and human recombinant H apoferritin[J]. Arch Biochem Biophys, 1996, 325（1）：58-64.
[72]
Heywood BR. Synthesis of inorganic nanophase materials in supramolecular protein cages[J]. Nature, 1991, 349（6311）：684-687.
[73]
Uchida M, Flenniken ML, Allen M, et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles[J]. J Am Chem Soc, 2006, 128（51）：16626-16633.
[74]
Cadenas E. Biochemistry of oxygen toxicity[J]. Annu Rev Biochem, 1989, 58：79-110.
[75]
Levi S, Arosio P. Mitochondrial ferritin[J]. Int J Biochem Cell Biol, 2004, 36（10）：1887-1889.
[76]
Jezequel P, Campion L, Spyratos F, et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors：A multicentric 2004 national PHRC study[J]. Int J Cancer, 2012, 131（2）：426-437.
[77]
Gray CP, Arosio P, Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma[J]. Clin Cancer Res, 2003, 9（7）：2551-2559.
[78]
Fantechi E, Innocenti C, Zanardelli M, et al. A smart platform for hyperthermia application in cancer treatment：cobalt-doped ferrite nanoparticles mineralized in human ferritin cages[J]. ACS Nano, 2014, 8（5）：4705-4719.
[79]
Szymendera JJ, Kozlowicz-Gudzinska I, Madej G, et al. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors[J]. Oncology, 1985, 42（4）：253-258.
[80]
Matzner Y, Konijn AM, Hershko C. Serum ferritin in hematologic malignancies[J]. Am J Hematol, 1980, 9（1）：13-22.
[81]
Daniels TR, Delgado T, Helguera G, et al. The transferrin receptor part II：targeted delivery of therapeutic agents into cancer cells[J]. Clin Immunol, 2006, 121（2）：159-176.
[82]
Daniels TR, Bernabeu E, Rodriguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer[J]. Biochim Biophys Acta, 2012, 1820（3）：291-317.
[83]
Doshi N, Mitragotri S. Designer biomaterials for nanomedicine[J]. Advanced Functional Materials, 2009, 19（24）：3843-3854.
